Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001739410-25-000061
Filing Date
2025-05-08
Accepted
2025-05-08 08:22:09
Documents
68
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rlyb-20250331.htm   iXBRL 10-Q 1050006
2 EX-31.1 rlyb-20250331xex311.htm EX-31.1 10284
3 EX-31.2 rlyb-20250331xex312.htm EX-31.2 10273
4 EX-32.1 rlyb-20250331xex321.htm EX-32.1 4843
5 EX-32.2 rlyb-2025331xex322.htm EX-32.2 4824
11 rlyb-20250331_g1.jpg GRAPHIC 8945
  Complete submission text file 0001739410-25-000061.txt   5240506

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20250331.xsd EX-101.SCH 33437
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlyb-20250331_cal.xml EX-101.CAL 46839
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlyb-20250331_def.xml EX-101.DEF 185359
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20250331_lab.xml EX-101.LAB 523804
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20250331_pre.xml EX-101.PRE 369723
71 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20250331_htm.xml XML 468405
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

EIN.: 851083789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40693 | Film No.: 25924025
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)